nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2D6—Lomustine—hematologic cancer	0.0628	0.104	CbGbCtD
Benzatropine—CYP2D6—Idarubicin—hematologic cancer	0.056	0.0926	CbGbCtD
Benzatropine—CYP2C19—Bortezomib—hematologic cancer	0.0545	0.0901	CbGbCtD
Benzatropine—CYP2D6—Hydroxyurea—hematologic cancer	0.0476	0.0788	CbGbCtD
Benzatropine—CYP2C19—Thalidomide—hematologic cancer	0.0475	0.0785	CbGbCtD
Benzatropine—CYP2C19—Teniposide—hematologic cancer	0.0453	0.0749	CbGbCtD
Benzatropine—CYP2C19—Ifosfamide—hematologic cancer	0.0418	0.0691	CbGbCtD
Benzatropine—CYP2D6—Bortezomib—hematologic cancer	0.0414	0.0685	CbGbCtD
Benzatropine—CYP2C19—Imatinib—hematologic cancer	0.0399	0.066	CbGbCtD
Benzatropine—CYP2D6—Imatinib—hematologic cancer	0.0304	0.0502	CbGbCtD
Benzatropine—CYP2D6—Nilotinib—hematologic cancer	0.0276	0.0456	CbGbCtD
Benzatropine—CYP2D6—Vinorelbine—hematologic cancer	0.0274	0.0452	CbGbCtD
Benzatropine—CYP2C19—Prednisone—hematologic cancer	0.0263	0.0435	CbGbCtD
Benzatropine—CYP2D6—Vinblastine—hematologic cancer	0.0169	0.0279	CbGbCtD
Benzatropine—CYP2C19—Dexamethasone—hematologic cancer	0.0164	0.0272	CbGbCtD
Benzatropine—CYP2D6—Dexamethasone—hematologic cancer	0.0125	0.0207	CbGbCtD
Benzatropine—CYP2D6—Doxorubicin—hematologic cancer	0.0104	0.0171	CbGbCtD
Benzatropine—Feeling abnormal—Bortezomib—hematologic cancer	0.000353	0.00117	CcSEcCtD
Benzatropine—Hypersensitivity—Melphalan—hematologic cancer	0.000352	0.00117	CcSEcCtD
Benzatropine—Nausea—Procarbazine—hematologic cancer	0.000352	0.00117	CcSEcCtD
Benzatropine—Feeling abnormal—Bleomycin—hematologic cancer	0.00035	0.00117	CcSEcCtD
Benzatropine—Vomiting—Chlorambucil—hematologic cancer	0.000349	0.00116	CcSEcCtD
Benzatropine—Confusional state—Mitoxantrone—hematologic cancer	0.000347	0.00116	CcSEcCtD
Benzatropine—Confusional state—Irinotecan—hematologic cancer	0.000347	0.00116	CcSEcCtD
Benzatropine—Decreased appetite—Thiotepa—hematologic cancer	0.000347	0.00116	CcSEcCtD
Benzatropine—Nausea—Bexarotene—hematologic cancer	0.000345	0.00115	CcSEcCtD
Benzatropine—Nausea—Dasatinib—hematologic cancer	0.000345	0.00115	CcSEcCtD
Benzatropine—Feeling abnormal—Vinorelbine—hematologic cancer	0.000344	0.00115	CcSEcCtD
Benzatropine—Nausea—Fludarabine—hematologic cancer	0.000344	0.00115	CcSEcCtD
Benzatropine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000342	0.00114	CcSEcCtD
Benzatropine—Constipation—Thiotepa—hematologic cancer	0.000341	0.00114	CcSEcCtD
Benzatropine—Vomiting—Nilotinib—hematologic cancer	0.000341	0.00114	CcSEcCtD
Benzatropine—Vomiting—Imatinib—hematologic cancer	0.000339	0.00113	CcSEcCtD
Benzatropine—Rash—Nilotinib—hematologic cancer	0.000338	0.00113	CcSEcCtD
Benzatropine—Body temperature increased—Bortezomib—hematologic cancer	0.000338	0.00113	CcSEcCtD
Benzatropine—Dermatitis—Nilotinib—hematologic cancer	0.000338	0.00113	CcSEcCtD
Benzatropine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000338	0.00113	CcSEcCtD
Benzatropine—Rash—Imatinib—hematologic cancer	0.000336	0.00112	CcSEcCtD
Benzatropine—Tachycardia—Mitoxantrone—hematologic cancer	0.000336	0.00112	CcSEcCtD
Benzatropine—Dermatitis—Imatinib—hematologic cancer	0.000336	0.00112	CcSEcCtD
Benzatropine—Body temperature increased—Bleomycin—hematologic cancer	0.000336	0.00112	CcSEcCtD
Benzatropine—Decreased appetite—Thalidomide—hematologic cancer	0.000335	0.00112	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—hematologic cancer	0.000333	0.00111	CcSEcCtD
Benzatropine—Vomiting—Cladribine—hematologic cancer	0.000333	0.00111	CcSEcCtD
Benzatropine—Rash—Cladribine—hematologic cancer	0.00033	0.0011	CcSEcCtD
Benzatropine—Body temperature increased—Vinorelbine—hematologic cancer	0.00033	0.0011	CcSEcCtD
Benzatropine—Dermatitis—Cladribine—hematologic cancer	0.00033	0.0011	CcSEcCtD
Benzatropine—Constipation—Thalidomide—hematologic cancer	0.00033	0.0011	CcSEcCtD
Benzatropine—Feeling abnormal—Thiotepa—hematologic cancer	0.000329	0.0011	CcSEcCtD
Benzatropine—Vision blurred—Prednisolone—hematologic cancer	0.000326	0.00109	CcSEcCtD
Benzatropine—Nausea—Chlorambucil—hematologic cancer	0.000326	0.00109	CcSEcCtD
Benzatropine—Decreased appetite—Carmustine—hematologic cancer	0.000322	0.00107	CcSEcCtD
Benzatropine—Vomiting—Vinblastine—hematologic cancer	0.00032	0.00107	CcSEcCtD
Benzatropine—Decreased appetite—Alitretinoin—hematologic cancer	0.000319	0.00106	CcSEcCtD
Benzatropine—Nausea—Nilotinib—hematologic cancer	0.000319	0.00106	CcSEcCtD
Benzatropine—Feeling abnormal—Thalidomide—hematologic cancer	0.000318	0.00106	CcSEcCtD
Benzatropine—Constipation—Carmustine—hematologic cancer	0.000317	0.00106	CcSEcCtD
Benzatropine—Nausea—Imatinib—hematologic cancer	0.000317	0.00106	CcSEcCtD
Benzatropine—Decreased appetite—Ifosfamide—hematologic cancer	0.000315	0.00105	CcSEcCtD
Benzatropine—Body temperature increased—Thiotepa—hematologic cancer	0.000315	0.00105	CcSEcCtD
Benzatropine—Hypersensitivity—Bortezomib—hematologic cancer	0.000315	0.00105	CcSEcCtD
Benzatropine—Constipation—Alitretinoin—hematologic cancer	0.000314	0.00105	CcSEcCtD
Benzatropine—Hypersensitivity—Bleomycin—hematologic cancer	0.000313	0.00104	CcSEcCtD
Benzatropine—Nausea—Cladribine—hematologic cancer	0.000311	0.00104	CcSEcCtD
Benzatropine—Constipation—Ifosfamide—hematologic cancer	0.00031	0.00103	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—hematologic cancer	0.000309	0.00103	CcSEcCtD
Benzatropine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000308	0.00103	CcSEcCtD
Benzatropine—Decreased appetite—Vincristine—hematologic cancer	0.000307	0.00102	CcSEcCtD
Benzatropine—Feeling abnormal—Carmustine—hematologic cancer	0.000305	0.00102	CcSEcCtD
Benzatropine—Tachycardia—Cisplatin—hematologic cancer	0.000305	0.00102	CcSEcCtD
Benzatropine—Body temperature increased—Thalidomide—hematologic cancer	0.000305	0.00102	CcSEcCtD
Benzatropine—Vomiting—Melphalan—hematologic cancer	0.000304	0.00101	CcSEcCtD
Benzatropine—Feeling abnormal—Alitretinoin—hematologic cancer	0.000302	0.00101	CcSEcCtD
Benzatropine—Constipation—Vincristine—hematologic cancer	0.000302	0.00101	CcSEcCtD
Benzatropine—Rash—Melphalan—hematologic cancer	0.000301	0.001	CcSEcCtD
Benzatropine—Dermatitis—Melphalan—hematologic cancer	0.000301	0.001	CcSEcCtD
Benzatropine—Decreased appetite—Irinotecan—hematologic cancer	0.000299	0.000998	CcSEcCtD
Benzatropine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000299	0.000998	CcSEcCtD
Benzatropine—Feeling abnormal—Ifosfamide—hematologic cancer	0.000299	0.000997	CcSEcCtD
Benzatropine—Nausea—Vinblastine—hematologic cancer	0.000299	0.000995	CcSEcCtD
Benzatropine—Vomiting—Lenalidomide—hematologic cancer	0.000296	0.000985	CcSEcCtD
Benzatropine—Constipation—Mitoxantrone—hematologic cancer	0.000295	0.000982	CcSEcCtD
Benzatropine—Constipation—Irinotecan—hematologic cancer	0.000295	0.000982	CcSEcCtD
Benzatropine—Hypersensitivity—Thiotepa—hematologic cancer	0.000294	0.00098	CcSEcCtD
Benzatropine—Rash—Lenalidomide—hematologic cancer	0.000293	0.000977	CcSEcCtD
Benzatropine—Body temperature increased—Carmustine—hematologic cancer	0.000293	0.000976	CcSEcCtD
Benzatropine—Dermatitis—Lenalidomide—hematologic cancer	0.000293	0.000976	CcSEcCtD
Benzatropine—Decreased appetite—Gemcitabine—hematologic cancer	0.000292	0.000972	CcSEcCtD
Benzatropine—Vomiting—Hydroxyurea—hematologic cancer	0.000291	0.000971	CcSEcCtD
Benzatropine—Body temperature increased—Alitretinoin—hematologic cancer	0.00029	0.000967	CcSEcCtD
Benzatropine—Rash—Hydroxyurea—hematologic cancer	0.000289	0.000963	CcSEcCtD
Benzatropine—Confusional state—Etoposide—hematologic cancer	0.000289	0.000963	CcSEcCtD
Benzatropine—Dermatitis—Hydroxyurea—hematologic cancer	0.000289	0.000962	CcSEcCtD
Benzatropine—Constipation—Gemcitabine—hematologic cancer	0.000287	0.000956	CcSEcCtD
Benzatropine—Body temperature increased—Ifosfamide—hematologic cancer	0.000287	0.000956	CcSEcCtD
Benzatropine—Hypersensitivity—Thalidomide—hematologic cancer	0.000284	0.000947	CcSEcCtD
Benzatropine—Nausea—Melphalan—hematologic cancer	0.000284	0.000947	CcSEcCtD
Benzatropine—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000284	0.000946	CcSEcCtD
Benzatropine—Feeling abnormal—Irinotecan—hematologic cancer	0.000284	0.000946	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—hematologic cancer	0.000282	0.000941	CcSEcCtD
Benzatropine—Dysuria—Methotrexate—hematologic cancer	0.000282	0.000941	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—hematologic cancer	0.00028	0.000932	CcSEcCtD
Benzatropine—Body temperature increased—Vincristine—hematologic cancer	0.00028	0.000932	CcSEcCtD
Benzatropine—Feeling abnormal—Gemcitabine—hematologic cancer	0.000277	0.000922	CcSEcCtD
Benzatropine—Nausea—Lenalidomide—hematologic cancer	0.000276	0.00092	CcSEcCtD
Benzatropine—Tachycardia—Prednisolone—hematologic cancer	0.000276	0.000919	CcSEcCtD
Benzatropine—Hypersensitivity—Carmustine—hematologic cancer	0.000273	0.00091	CcSEcCtD
Benzatropine—Body temperature increased—Irinotecan—hematologic cancer	0.000272	0.000908	CcSEcCtD
Benzatropine—Body temperature increased—Mitoxantrone—hematologic cancer	0.000272	0.000908	CcSEcCtD
Benzatropine—Nausea—Hydroxyurea—hematologic cancer	0.000272	0.000908	CcSEcCtD
Benzatropine—Vomiting—Bortezomib—hematologic cancer	0.000272	0.000907	CcSEcCtD
Benzatropine—Decreased appetite—Cisplatin—hematologic cancer	0.000272	0.000906	CcSEcCtD
Benzatropine—Hypersensitivity—Alitretinoin—hematologic cancer	0.00027	0.000901	CcSEcCtD
Benzatropine—Vomiting—Bleomycin—hematologic cancer	0.00027	0.0009	CcSEcCtD
Benzatropine—Rash—Bortezomib—hematologic cancer	0.00027	0.000899	CcSEcCtD
Benzatropine—Dermatitis—Bortezomib—hematologic cancer	0.000269	0.000898	CcSEcCtD
Benzatropine—Rash—Bleomycin—hematologic cancer	0.000268	0.000892	CcSEcCtD
Benzatropine—Dermatitis—Bleomycin—hematologic cancer	0.000267	0.000891	CcSEcCtD
Benzatropine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000267	0.000891	CcSEcCtD
Benzatropine—Vomiting—Vinorelbine—hematologic cancer	0.000266	0.000885	CcSEcCtD
Benzatropine—Body temperature increased—Gemcitabine—hematologic cancer	0.000265	0.000884	CcSEcCtD
Benzatropine—Dry mouth—Triamcinolone—hematologic cancer	0.000265	0.000884	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—hematologic cancer	0.000264	0.00088	CcSEcCtD
Benzatropine—Rash—Vinorelbine—hematologic cancer	0.000263	0.000878	CcSEcCtD
Benzatropine—Dermatitis—Vinorelbine—hematologic cancer	0.000263	0.000877	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—hematologic cancer	0.000261	0.000871	CcSEcCtD
Benzatropine—Hypersensitivity—Vincristine—hematologic cancer	0.000261	0.000869	CcSEcCtD
Benzatropine—Feeling abnormal—Cisplatin—hematologic cancer	0.000258	0.000859	CcSEcCtD
Benzatropine—Nausea—Bortezomib—hematologic cancer	0.000254	0.000847	CcSEcCtD
Benzatropine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000254	0.000846	CcSEcCtD
Benzatropine—Hypersensitivity—Irinotecan—hematologic cancer	0.000254	0.000846	CcSEcCtD
Benzatropine—Tachycardia—Triamcinolone—hematologic cancer	0.000254	0.000845	CcSEcCtD
Benzatropine—Vomiting—Thiotepa—hematologic cancer	0.000254	0.000845	CcSEcCtD
Benzatropine—Nausea—Bleomycin—hematologic cancer	0.000252	0.00084	CcSEcCtD
Benzatropine—Rash—Thiotepa—hematologic cancer	0.000252	0.000838	CcSEcCtD
Benzatropine—Dermatitis—Thiotepa—hematologic cancer	0.000251	0.000838	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—hematologic cancer	0.000249	0.00083	CcSEcCtD
Benzatropine—Nausea—Vinorelbine—hematologic cancer	0.000248	0.000827	CcSEcCtD
Benzatropine—Body temperature increased—Cisplatin—hematologic cancer	0.000247	0.000824	CcSEcCtD
Benzatropine—Vomiting—Thalidomide—hematologic cancer	0.000245	0.000818	CcSEcCtD
Benzatropine—Constipation—Etoposide—hematologic cancer	0.000245	0.000817	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—hematologic cancer	0.000244	0.000815	CcSEcCtD
Benzatropine—Rash—Thalidomide—hematologic cancer	0.000243	0.000811	CcSEcCtD
Benzatropine—Dermatitis—Thalidomide—hematologic cancer	0.000243	0.00081	CcSEcCtD
Benzatropine—Vision blurred—Prednisone—hematologic cancer	0.000237	0.00079	CcSEcCtD
Benzatropine—Nausea—Thiotepa—hematologic cancer	0.000237	0.00079	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—hematologic cancer	0.000236	0.000787	CcSEcCtD
Benzatropine—Vomiting—Carmustine—hematologic cancer	0.000236	0.000785	CcSEcCtD
Benzatropine—Rash—Carmustine—hematologic cancer	0.000234	0.000779	CcSEcCtD
Benzatropine—Dermatitis—Carmustine—hematologic cancer	0.000233	0.000778	CcSEcCtD
Benzatropine—Vomiting—Alitretinoin—hematologic cancer	0.000233	0.000778	CcSEcCtD
Benzatropine—Feeling abnormal—Prednisolone—hematologic cancer	0.000233	0.000776	CcSEcCtD
Benzatropine—Rash—Alitretinoin—hematologic cancer	0.000231	0.000771	CcSEcCtD
Benzatropine—Dermatitis—Alitretinoin—hematologic cancer	0.000231	0.000771	CcSEcCtD
Benzatropine—Vomiting—Ifosfamide—hematologic cancer	0.000231	0.000769	CcSEcCtD
Benzatropine—Hypersensitivity—Cisplatin—hematologic cancer	0.00023	0.000768	CcSEcCtD
Benzatropine—Tachycardia—Dexamethasone—hematologic cancer	0.00023	0.000767	CcSEcCtD
Benzatropine—Tachycardia—Betamethasone—hematologic cancer	0.00023	0.000767	CcSEcCtD
Benzatropine—Nausea—Thalidomide—hematologic cancer	0.000229	0.000764	CcSEcCtD
Benzatropine—Rash—Ifosfamide—hematologic cancer	0.000229	0.000762	CcSEcCtD
Benzatropine—Dermatitis—Ifosfamide—hematologic cancer	0.000229	0.000762	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—hematologic cancer	0.000227	0.000755	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—hematologic cancer	0.000225	0.00075	CcSEcCtD
Benzatropine—Vomiting—Vincristine—hematologic cancer	0.000225	0.00075	CcSEcCtD
Benzatropine—Rash—Vincristine—hematologic cancer	0.000223	0.000743	CcSEcCtD
Benzatropine—Dermatitis—Vincristine—hematologic cancer	0.000223	0.000743	CcSEcCtD
Benzatropine—Nausea—Carmustine—hematologic cancer	0.00022	0.000734	CcSEcCtD
Benzatropine—Vomiting—Mitoxantrone—hematologic cancer	0.000219	0.00073	CcSEcCtD
Benzatropine—Vomiting—Irinotecan—hematologic cancer	0.000219	0.00073	CcSEcCtD
Benzatropine—Nausea—Alitretinoin—hematologic cancer	0.000218	0.000727	CcSEcCtD
Benzatropine—Rash—Mitoxantrone—hematologic cancer	0.000217	0.000724	CcSEcCtD
Benzatropine—Rash—Irinotecan—hematologic cancer	0.000217	0.000724	CcSEcCtD
Benzatropine—Dermatitis—Irinotecan—hematologic cancer	0.000217	0.000723	CcSEcCtD
Benzatropine—Dermatitis—Mitoxantrone—hematologic cancer	0.000217	0.000723	CcSEcCtD
Benzatropine—Nausea—Ifosfamide—hematologic cancer	0.000215	0.000718	CcSEcCtD
Benzatropine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000214	0.000714	CcSEcCtD
Benzatropine—Vomiting—Gemcitabine—hematologic cancer	0.000213	0.000711	CcSEcCtD
Benzatropine—Rash—Gemcitabine—hematologic cancer	0.000212	0.000705	CcSEcCtD
Benzatropine—Dermatitis—Gemcitabine—hematologic cancer	0.000211	0.000705	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—hematologic cancer	0.000211	0.000704	CcSEcCtD
Benzatropine—Nausea—Vincristine—hematologic cancer	0.00021	0.0007	CcSEcCtD
Benzatropine—Hypersensitivity—Prednisolone—hematologic cancer	0.000208	0.000694	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000208	0.000694	CcSEcCtD
Benzatropine—Body temperature increased—Triamcinolone—hematologic cancer	0.000205	0.000685	CcSEcCtD
Benzatropine—Decreased appetite—Dexamethasone—hematologic cancer	0.000205	0.000683	CcSEcCtD
Benzatropine—Decreased appetite—Betamethasone—hematologic cancer	0.000205	0.000683	CcSEcCtD
Benzatropine—Nausea—Irinotecan—hematologic cancer	0.000205	0.000682	CcSEcCtD
Benzatropine—Nausea—Mitoxantrone—hematologic cancer	0.000205	0.000682	CcSEcCtD
Benzatropine—Tachycardia—Prednisone—hematologic cancer	0.0002	0.000668	CcSEcCtD
Benzatropine—Nausea—Gemcitabine—hematologic cancer	0.000199	0.000664	CcSEcCtD
Benzatropine—Vomiting—Cisplatin—hematologic cancer	0.000199	0.000663	CcSEcCtD
Benzatropine—Vision blurred—Methotrexate—hematologic cancer	0.000198	0.000661	CcSEcCtD
Benzatropine—Rash—Cisplatin—hematologic cancer	0.000197	0.000657	CcSEcCtD
Benzatropine—Dermatitis—Cisplatin—hematologic cancer	0.000197	0.000657	CcSEcCtD
Benzatropine—Feeling abnormal—Betamethasone—hematologic cancer	0.000194	0.000648	CcSEcCtD
Benzatropine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000194	0.000648	CcSEcCtD
Benzatropine—Tension—Epirubicin—hematologic cancer	0.000193	0.000644	CcSEcCtD
Benzatropine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000191	0.000638	CcSEcCtD
Benzatropine—Nervousness—Epirubicin—hematologic cancer	0.000191	0.000637	CcSEcCtD
Benzatropine—Body temperature increased—Betamethasone—hematologic cancer	0.000186	0.000621	CcSEcCtD
Benzatropine—Body temperature increased—Dexamethasone—hematologic cancer	0.000186	0.000621	CcSEcCtD
Benzatropine—Nausea—Cisplatin—hematologic cancer	0.000186	0.000619	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—hematologic cancer	0.000185	0.000618	CcSEcCtD
Benzatropine—Vomiting—Etoposide—hematologic cancer	0.000182	0.000607	CcSEcCtD
Benzatropine—Rash—Etoposide—hematologic cancer	0.000181	0.000602	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—hematologic cancer	0.00018	0.000602	CcSEcCtD
Benzatropine—Tension—Doxorubicin—hematologic cancer	0.000179	0.000596	CcSEcCtD
Benzatropine—Decreased appetite—Prednisone—hematologic cancer	0.000179	0.000595	CcSEcCtD
Benzatropine—Rash—Prednisolone—hematologic cancer	0.000178	0.000594	CcSEcCtD
Benzatropine—Dermatitis—Prednisolone—hematologic cancer	0.000178	0.000593	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—hematologic cancer	0.000177	0.00059	CcSEcCtD
Benzatropine—Constipation—Prednisone—hematologic cancer	0.000176	0.000585	CcSEcCtD
Benzatropine—Confusional state—Methotrexate—hematologic cancer	0.000173	0.000577	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—hematologic cancer	0.000172	0.000572	CcSEcCtD
Benzatropine—Nausea—Etoposide—hematologic cancer	0.00017	0.000567	CcSEcCtD
Benzatropine—Feeling abnormal—Prednisone—hematologic cancer	0.000169	0.000564	CcSEcCtD
Benzatropine—Nausea—Prednisolone—hematologic cancer	0.000168	0.00056	CcSEcCtD
Benzatropine—Vomiting—Triamcinolone—hematologic cancer	0.000165	0.000551	CcSEcCtD
Benzatropine—Rash—Triamcinolone—hematologic cancer	0.000164	0.000546	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—hematologic cancer	0.000164	0.000546	CcSEcCtD
Benzatropine—Dermatitis—Triamcinolone—hematologic cancer	0.000164	0.000546	CcSEcCtD
Benzatropine—Body temperature increased—Prednisone—hematologic cancer	0.000162	0.000541	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—hematologic cancer	0.000162	0.00054	CcSEcCtD
Benzatropine—Tachycardia—Epirubicin—hematologic cancer	0.000157	0.000523	CcSEcCtD
Benzatropine—Nausea—Triamcinolone—hematologic cancer	0.000154	0.000515	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—hematologic cancer	0.000152	0.000505	CcSEcCtD
Benzatropine—Hypersensitivity—Prednisone—hematologic cancer	0.000151	0.000504	CcSEcCtD
Benzatropine—Vomiting—Betamethasone—hematologic cancer	0.00015	0.0005	CcSEcCtD
Benzatropine—Vomiting—Dexamethasone—hematologic cancer	0.00015	0.0005	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—hematologic cancer	0.00015	0.000499	CcSEcCtD
Benzatropine—Decreased appetite—Methotrexate—hematologic cancer	0.000149	0.000497	CcSEcCtD
Benzatropine—Rash—Betamethasone—hematologic cancer	0.000149	0.000496	CcSEcCtD
Benzatropine—Rash—Dexamethasone—hematologic cancer	0.000149	0.000496	CcSEcCtD
Benzatropine—Dermatitis—Dexamethasone—hematologic cancer	0.000149	0.000495	CcSEcCtD
Benzatropine—Dermatitis—Betamethasone—hematologic cancer	0.000149	0.000495	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—hematologic cancer	0.000145	0.000483	CcSEcCtD
Benzatropine—Feeling abnormal—Methotrexate—hematologic cancer	0.000141	0.000471	CcSEcCtD
Benzatropine—Nausea—Dexamethasone—hematologic cancer	0.00014	0.000467	CcSEcCtD
Benzatropine—Nausea—Betamethasone—hematologic cancer	0.00014	0.000467	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—hematologic cancer	0.00014	0.000465	CcSEcCtD
Benzatropine—Constipation—Epirubicin—hematologic cancer	0.000137	0.000458	CcSEcCtD
Benzatropine—Body temperature increased—Methotrexate—hematologic cancer	0.000136	0.000452	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—hematologic cancer	0.000132	0.000441	CcSEcCtD
Benzatropine—Vomiting—Prednisone—hematologic cancer	0.000131	0.000435	CcSEcCtD
Benzatropine—Rash—Prednisone—hematologic cancer	0.000129	0.000432	CcSEcCtD
Benzatropine—Dermatitis—Prednisone—hematologic cancer	0.000129	0.000431	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—hematologic cancer	0.000129	0.000431	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—hematologic cancer	0.000127	0.000424	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—hematologic cancer	0.000127	0.000423	CcSEcCtD
Benzatropine—Hypersensitivity—Methotrexate—hematologic cancer	0.000126	0.000421	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000122	0.000408	CcSEcCtD
Benzatropine—Nausea—Prednisone—hematologic cancer	0.000122	0.000407	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—hematologic cancer	0.000118	0.000394	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—hematologic cancer	0.000117	0.000392	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000109	0.000365	CcSEcCtD
Benzatropine—Vomiting—Methotrexate—hematologic cancer	0.000109	0.000364	CcSEcCtD
Benzatropine—Rash—Methotrexate—hematologic cancer	0.000108	0.000361	CcSEcCtD
Benzatropine—Dermatitis—Methotrexate—hematologic cancer	0.000108	0.00036	CcSEcCtD
Benzatropine—Vomiting—Epirubicin—hematologic cancer	0.000102	0.00034	CcSEcCtD
Benzatropine—Nausea—Methotrexate—hematologic cancer	0.000102	0.00034	CcSEcCtD
Benzatropine—Rash—Epirubicin—hematologic cancer	0.000101	0.000338	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—hematologic cancer	0.000101	0.000337	CcSEcCtD
Benzatropine—Nausea—Epirubicin—hematologic cancer	9.54e-05	0.000318	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—hematologic cancer	9.45e-05	0.000315	CcSEcCtD
Benzatropine—Rash—Doxorubicin—hematologic cancer	9.37e-05	0.000312	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—hematologic cancer	9.36e-05	0.000312	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—hematologic cancer	8.83e-05	0.000294	CcSEcCtD
Benzatropine—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	1.21e-05	0.000127	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HES1—hematologic cancer	1.2e-05	0.000126	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGF1—hematologic cancer	1.2e-05	0.000126	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CSF2—hematologic cancer	1.2e-05	0.000126	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.2e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGF1—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CSF2—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	1.18e-05	0.000124	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	1.18e-05	0.000124	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CSF2—hematologic cancer	1.18e-05	0.000124	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGF1—hematologic cancer	1.18e-05	0.000124	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	1.18e-05	0.000124	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	1.18e-05	0.000123	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	1.18e-05	0.000123	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.18e-05	0.000123	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	1.17e-05	0.000122	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.16e-05	0.000122	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.16e-05	0.000122	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.16e-05	0.000122	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	1.16e-05	0.000122	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.16e-05	0.000122	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.16e-05	0.000121	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JAK1—hematologic cancer	1.16e-05	0.000121	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	1.16e-05	0.000121	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYCS—hematologic cancer	1.16e-05	0.000121	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	1.15e-05	0.000121	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JAK1—hematologic cancer	1.15e-05	0.000121	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.15e-05	0.00012	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.15e-05	0.00012	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.14e-05	0.00012	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1.14e-05	0.000119	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1.14e-05	0.000119	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CD44—hematologic cancer	1.12e-05	0.000118	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NQO1—hematologic cancer	1.12e-05	0.000118	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	1.08e-05	0.000113	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	1.08e-05	0.000113	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—hematologic cancer	1.07e-05	0.000112	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—hematologic cancer	1.07e-05	0.000112	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TERT—hematologic cancer	1.07e-05	0.000112	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TERT—hematologic cancer	1.06e-05	0.000112	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYCS—hematologic cancer	1.06e-05	0.000111	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.06e-05	0.000111	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.06e-05	0.000111	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.05e-05	0.000111	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.05e-05	0.00011	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	1.04e-05	0.000109	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	1.04e-05	0.000109	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.03e-05	0.000108	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.03e-05	0.000108	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TSC2—hematologic cancer	1.02e-05	0.000107	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.02e-05	0.000107	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	1.02e-05	0.000106	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1e-05	0.000105	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.86e-06	0.000103	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	9.8e-06	0.000103	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	9.77e-06	0.000102	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	9.71e-06	0.000102	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	9.67e-06	0.000101	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	9.65e-06	0.000101	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ABCB1—hematologic cancer	9.64e-06	0.000101	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	9.55e-06	0.0001	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ESR1—hematologic cancer	9.52e-06	9.98e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	9.49e-06	9.95e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FN1—hematologic cancer	9.4e-06	9.86e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FN1—hematologic cancer	9.37e-06	9.83e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—hematologic cancer	9.37e-06	9.83e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	9.37e-06	9.82e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NCOR1—hematologic cancer	9.36e-06	9.82e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—hematologic cancer	9.36e-06	9.82e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	9.29e-06	9.74e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—BAD—hematologic cancer	9.29e-06	9.74e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—BAD—hematologic cancer	9.26e-06	9.71e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	9.26e-06	9.71e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FN1—hematologic cancer	9.25e-06	9.7e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	9.2e-06	9.65e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	9.17e-06	9.62e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—BAD—hematologic cancer	9.14e-06	9.59e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	9.14e-06	9.59e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	9.06e-06	9.49e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CD80—hematologic cancer	9.02e-06	9.45e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	9e-06	9.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KIT—hematologic cancer	9e-06	9.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	9e-06	9.44e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CD80—hematologic cancer	8.99e-06	9.42e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KIT—hematologic cancer	8.97e-06	9.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	8.97e-06	9.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	8.97e-06	9.41e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CD80—hematologic cancer	8.87e-06	9.3e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ABCB1—hematologic cancer	8.87e-06	9.3e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	8.86e-06	9.28e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KIT—hematologic cancer	8.86e-06	9.28e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	8.86e-06	9.28e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	8.84e-06	9.27e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	8.81e-06	9.24e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	8.7e-06	9.12e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	8.62e-06	9.04e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NCOR1—hematologic cancer	8.61e-06	9.03e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—hematologic cancer	8.61e-06	9.03e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	8.59e-06	9.01e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CREB1—hematologic cancer	8.57e-06	8.98e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	8.54e-06	8.95e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	8.48e-06	8.89e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—BRAF—hematologic cancer	8.46e-06	8.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	8.43e-06	8.84e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	8.43e-06	8.84e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCL2—hematologic cancer	8.38e-06	8.79e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6R—hematologic cancer	8.36e-06	8.76e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	8.35e-06	8.76e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	8.34e-06	8.75e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	8.33e-06	8.73e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	8.32e-06	8.73e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	8.32e-06	8.72e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—MTHFR—hematologic cancer	8.27e-06	8.68e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	8.25e-06	8.65e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	8.22e-06	8.62e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	8.21e-06	8.61e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	7.96e-06	8.35e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	7.94e-06	8.32e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	7.91e-06	8.3e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	7.89e-06	8.27e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.84e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	7.84e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.81e-06	8.19e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	7.78e-06	8.16e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	7.75e-06	8.12e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	7.72e-06	8.1e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.71e-06	8.08e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	7.62e-06	7.99e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—MTHFR—hematologic cancer	7.61e-06	7.98e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGF2—hematologic cancer	7.58e-06	7.94e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	7.55e-06	7.92e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	7.47e-06	7.83e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	7.45e-06	7.81e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	7.45e-06	7.81e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	7.35e-06	7.71e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.29e-06	7.65e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JAK2—hematologic cancer	7.26e-06	7.61e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	7.24e-06	7.59e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	7.14e-06	7.49e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	7.12e-06	7.46e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	7.09e-06	7.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MDM2—hematologic cancer	7.09e-06	7.43e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	7.06e-06	7.41e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	7e-06	7.34e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	6.97e-06	7.31e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	6.95e-06	7.29e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	6.9e-06	7.23e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MTOR—hematologic cancer	6.9e-06	7.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	6.87e-06	7.21e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	6.87e-06	7.21e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	6.79e-06	7.11e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	6.79e-06	7.11e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	6.58e-06	6.9e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	6.56e-06	6.88e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	6.48e-06	6.79e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	6.47e-06	6.79e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	6.45e-06	6.76e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CREBBP—hematologic cancer	6.45e-06	6.76e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	6.4e-06	6.71e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	6.39e-06	6.7e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	6.38e-06	6.69e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	6.37e-06	6.68e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CASP3—hematologic cancer	6.34e-06	6.65e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—hematologic cancer	6.33e-06	6.64e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	6.32e-06	6.63e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—hematologic cancer	6.31e-06	6.62e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL6—hematologic cancer	6.3e-06	6.61e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	6.3e-06	6.6e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	6.28e-06	6.59e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	6.24e-06	6.54e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—hematologic cancer	6.23e-06	6.53e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	6.2e-06	6.5e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—hematologic cancer	6.17e-06	6.47e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JUN—hematologic cancer	6.16e-06	6.46e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	6.15e-06	6.45e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JUN—hematologic cancer	6.14e-06	6.44e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	6.11e-06	6.41e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	6.07e-06	6.37e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JUN—hematologic cancer	6.06e-06	6.36e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALB—hematologic cancer	6.03e-06	6.33e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	5.97e-06	6.26e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTEN—hematologic cancer	5.96e-06	6.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	5.95e-06	6.24e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	5.94e-06	6.23e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.93e-06	6.22e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	5.88e-06	6.16e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	5.83e-06	6.11e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	5.81e-06	6.1e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	5.81e-06	6.09e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	5.79e-06	6.08e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	5.77e-06	6.05e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	5.74e-06	6.01e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	5.72e-06	6e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EP300—hematologic cancer	5.68e-06	5.96e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EP300—hematologic cancer	5.66e-06	5.94e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.62e-06	5.89e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EP300—hematologic cancer	5.59e-06	5.86e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALB—hematologic cancer	5.55e-06	5.82e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SRC—hematologic cancer	5.53e-06	5.79e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SRC—hematologic cancer	5.51e-06	5.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SRC—hematologic cancer	5.44e-06	5.7e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	5.38e-06	5.64e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	5.36e-06	5.63e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STAT3—hematologic cancer	5.33e-06	5.59e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	5.33e-06	5.59e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NRAS—hematologic cancer	5.32e-06	5.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	5.31e-06	5.57e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	5.31e-06	5.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	5.3e-06	5.56e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	5.3e-06	5.55e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	5.24e-06	5.5e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	5.23e-06	5.48e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	5.09e-06	5.34e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	5.08e-06	5.32e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	5.01e-06	5.25e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—hematologic cancer	4.95e-06	5.19e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	4.94e-06	5.18e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—hematologic cancer	4.94e-06	5.18e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	4.92e-06	5.16e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.9e-06	5.14e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—hematologic cancer	4.87e-06	5.11e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	4.86e-06	5.1e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTEN—hematologic cancer	4.6e-06	4.83e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KRAS—hematologic cancer	4.58e-06	4.8e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	4.56e-06	4.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	4.5e-06	4.72e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—EP300—hematologic cancer	4.39e-06	4.6e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTEN—hematologic cancer	4.23e-06	4.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	4.2e-06	4.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	4.19e-06	4.39e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	4.14e-06	4.34e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—hematologic cancer	4.07e-06	4.26e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—hematologic cancer	4.05e-06	4.25e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—EP300—hematologic cancer	4.04e-06	4.23e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—hematologic cancer	4e-06	4.2e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HRAS—hematologic cancer	3.89e-06	4.08e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	3.88e-06	4.06e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	3.83e-06	4.01e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6—hematologic cancer	3.72e-06	3.9e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6—hematologic cancer	3.71e-06	3.89e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6—hematologic cancer	3.66e-06	3.84e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKT1—hematologic cancer	3.43e-06	3.6e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	3.42e-06	3.59e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	3.38e-06	3.54e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.25e-06	3.4e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.99e-06	3.13e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—AKT1—hematologic cancer	2.65e-06	2.78e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.44e-06	2.56e-05	CbGpPWpGaD
